CVS · 8-K · 20260805PR000097

Pharmacy Demand And Pricing

CVS HEALTH Corp · 2026-08-05 · Importance 54 · Surprise 40

Health Services revenue increased 11.5% to $51.8 billion, primarily reflecting pharmacy drug mix and brand inflation, partly offset by continued pharmacy client price improvements. Pharmacy claims processed were essentially stable at 473.0 million on a 30-day equivalent basis versus 469.0 million a year earlier, indicating limited underlying volume growth in the PBM channel. Pharmacy & Consumer Wellness prescriptions filled increased 4.3% to 457.0 million, driven by Rite Aid prescription-file acquisitions and higher utilization. Revenue growth in the retail pharmacy business was constrained by regulatory-related price reductions, new generic-drug introductions and pharmacy reimbursement pressure.

Key facts

• The Company completed Rite Aid asset acquisitions during the third quarter of 2025 and those contributed to increased prescription volume in Q2 2026 source
• Health Services total revenues increase of 11.5% for Q2 2026 was primarily driven by pharmacy drug mix and brand inflation, partially offset by continued pharmacy client price improvements source
• Pharmacy & Consumer Wellness prescription volume increase for Q2 2026: 7.0% source
• Health Services pharmacy claims processed for Q2 2026: 473.0 million versus 469.0 million in Q2 2025, change 4.0 million source
• Prescriptions filled for Pharmacy & Consumer Wellness in Q2 2026: 457.0 million versus 438.1 million in Q2 2025, change 18.9 million (4.3% on a 30-day equivalent basis) source